Pulmonary Embolism Market Size, Share, Trends and Forecast 2016
- Submitted by: rickybill
- Views: 69
- Category: Other
- Date Submitted: 04/25/2016 12:16 AM
- Pages: 2
- Report this Essay
Pulmonary Embolism Market Outlook, Business Overview and Analysis, Research and Development, Pipeline Review, H1 2016
Global Markets Direct's, 'Pulmonary Embolism - Pipeline Review, H1 2016', provides an overview of the Pulmonary Embolism pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pulmonary Embolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Embolism and features dormant and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/pulmonary-embolism-pipeline-review-h1-2016
Scope
The report provides a snapshot of the global therapeutic landscape of Pulmonary Embolism
The report reviews pipeline therapeutics for Pulmonary Embolism by companies and universities/research institutes based on information derived from company and industry-specific sources
Table Of Content
Table of Contents 2
List of Tables 4
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/167935
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Pulmonary Embolism Overview 6
Therapeutics Development 7
Pipeline...
Global Markets Direct's, 'Pulmonary Embolism - Pipeline Review, H1 2016', provides an overview of the Pulmonary Embolism pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Pulmonary Embolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Embolism and features dormant and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/pulmonary-embolism-pipeline-review-h1-2016
Scope
The report provides a snapshot of the global therapeutic landscape of Pulmonary Embolism
The report reviews pipeline therapeutics for Pulmonary Embolism by companies and universities/research institutes based on information derived from company and industry-specific sources
Table Of Content
Table of Contents 2
List of Tables 4
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/167935
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Pulmonary Embolism Overview 6
Therapeutics Development 7
Pipeline...